New Alzheimer's Treatments to Pace Doubling of U.S. Psychotherapeutic Drug Market.MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--June 22, 1995--Paced by new Alzheimer disease Alzheimer disease Degenerative brain disorder. It occurs in middle to late adult life, destroying neurons and connections in the cerebral cortex and resulting in significant loss of brain mass. treatments and increased anti-depressant use, U.S. sales of psychological therapeutic prescription drugs will more than double from $4.4 billion in 1994 to $9.3 billion by the year 2001, projects a new study just released by Frost & Sullivan. Dramatic advances in Alzheimer's treatment will increase the revenue share of drugs targeting that illness from 5 percent of the total market in 1994 to 19 percent in 2001 while anti-depressant medications also rise in share from 17 to 21 percent in the same period, forecasts the report, U.S. PSYCHOTHERAPEUTIC PHARMACEUTICAL MARKETS BY DISEASE: INCREASED AWARENESS OF DISEASES AND R&D SPENDING ACCELERATE GROWTH. In 1994, drugs targeted to treatment of anxiety accounted for 18 percent of market revenues, manic-depression 15 percent, alcohol abuse 11 percent, sleep disorders Sleep Disorders Definition Sleep disorders are a group of syndromes characterized by disturbance in the patient's amount of sleep, quality or timing of sleep, or in behaviors or physiological conditions associated with sleep. 10 percent, schizophrenia 9 percent, drug abuse 6 percent and attention deficit disorder attention deficit (hyperactivity) disorder (ADD or ADHD) formerly hyperactivity Behavioral syndrome in children, whose major symptoms are inattention and distractibility, restlessness, inability to sit still, and difficulty concentrating on one thing for any 4 percent, says the study. Other segments analyzed include eating disorders eating disorders, in psychology, disorders in eating patterns that comprise four categories: anorexia nervosa, bulimia, rumination disorder, and pica. Anorexia nervosa is characterized by self-starvation to avoid obesity. and Wericke Korsakoff's syndrome Korsakoff's Syndrome Definition Korsakoff's syndrome is a memory disorder which is caused by a deficiency of vitamin B1, also called thiamine. . A steady stream of new neurological therapeutics will hit the market during the next several years, revolutionizing the treatment of many diseases for which there have been no satisfactory treatments. Industry growth is being promoted by enhanced understanding of nervous system functioning and new product development, and supported by the population's aging. Research and development for psychological therapeutics is expected to surpass that for all other categories of drugs in the years ahead. Molecular neurobiology Neurobiology Study of the development and function of the nervous system, with emphasis on how nerve cells generate and control behavior. The major goal of neurobiology is to explain at the molecular level how nerve cells differentiate and develop their has advanced dramatically in recent years. Mapping of the genes has offered new understanding of possible causes of disorders. Researchers claim a majority of current human knowledge about the nervous system has been gained in the past decade. Technological developments supporting current neuroscience include brain-scanning made possible by MRI 1. (application) MRI - Magnetic Resonance Imaging. 2. MRI - Measurement Requirements and Interface. and PET that allow tracing of neural pathways and identification of distinct cell types, availability of computers for real-time data Real-time data denotes information that is delivered immediately after collection. There is no delay in the timeliness of the information provided. Some uses of this term confuse it with the term dynamic data. analysis and sophisticated stimulus creation, and molecular genetic tools including DNA DNA: see nucleic acid. DNA or deoxyribonucleic acid One of two types of nucleic acid (the other is RNA); a complex organic compound found in all living cells and many viruses. It is the chemical substance of genes. libraries, studies of protein expression and genetic mutants and markers. Smaller companies are making co-promotion agreements with bigger drug companies better equipped to finance and market, allowing the smaller firms to gain greater exposure for products and tap otherwise unavailable markets. Generics, favored for their low cost, hold some 70 percent of prescriptions in some markets, like narcotics narcotics n. 1) techinically, drugs which dull the senses. 2) a popular generic term for drugs which cannot be legally possessed, sold, or transported except for medicinal uses for which a physician or dentist's prescription is required. and analgesics Analgesics Definition Analgesics are medicines that relieve pain. Purpose Analgesics are those drugs that mainly provide pain relief. , but others remain dominated by more recently developed and effective proprietary drugs. Patent-protected Clorozil is considered most effective in treating schizophrenia and newer patent-protected antidepressants Antidepressants Medications prescribed to relieve major depression. Classes of antidepressants include selective serotonin reuptake inhibitors (fluoxetine/Prozac, sertraline/Zoloft), tricyclics (amitriptyline/ Elavil), MAOIs (phenelzine/Nardil), and heterocyclics are considered superior to older now-generic formulations. Frost & Sullivan is an international high-technology research firm. All Frost & Sullivan reports are based on extensive interviews with marketing and technical experts from selected companies in each market segment. Primary research is validated by thorough analysis of available secondary research. Frost & Sullivan is the leading publisher worldwide of high-technology research reports. Report: 5242-52 Publication Date: June 1995 Price: $2295. -0-
Total Psychotherapeutic Pharmaceuticals Market by
Disease:
Revenue Forecasts (U.S.),
1991-2001
Revenue
Revenues Growth Rate
Year ($ Billion) (%)
1991 3.56 ---
1992 3.75 5.3
1993 3.98 6.2
1994 4.38 10.0
1995 4.89 11.8
1996 5.53 13.0
1997 6.15 11.1
1998 6.82 10.9
1999 7.60 11.5
2000 8.43 10.9
2001 9.34 10.8
Compound Annual Growth Rate (1994-2001): 11.4%
Note: All figures are rounded. Source: Frost & Sullivan CONTACT: Frost & Sullivan Amy Arnell, 415/961-9000 (Mountain View) Kristina Menzefricke, 44 171 730 3438 (London) Nadge Keryhue, 33 1 4742 9127 (Paris) |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion